针对抗药性癌症的刺驱动机制
Jade S Miller1,2,3,4, Natalie E Bennett1,3,4,5, Julie A Rhoades1,2,3,4,5
1Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
由于细胞的可塑性,癌细胞可能会对治疗产生抵抗力. 刺 (Hh) 信号通路在这种耐药性中发挥着关键作用,推动癌症的进展和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症治疗耐药性是由于细胞可塑性的重大临床挑战.
- 幸存的癌细胞经常表现出改变的细胞信号和转录途径,导致扩散和转移.
- 刺 (Hh) 信号通路与各种癌症亚型有关,并且可以通过治疗来异常激活.
研究的目的:
- 审查当前对 (Hh) 信号传导在癌症药物耐药性中的作用的理解.
- 探索包括非正规Gli蛋白激活和基因放大赋予化疗耐受性的机制.
- 为了识别阻力中Hh信号的转录调节中的知识差距.
主要方法:
- 关于刺信号和癌症药物耐药性的科学出版物的文献评论.
- 对研究Gli蛋白激活和基因放大的研究进行分析.
- 检查对刺的向疗法和工具化合物的研究.
主要成果:
- 刺 (Hh) 信号是多种癌症治疗耐药性的重要贡献者.
- Gli 蛋白的非正规激活和基因放大是药物耐受性的关键机制.
- 针对刺的药物和工具化合物显示出潜力,但需要进一步调查.
结论:
- 刺 (Hh) 信号是癌症抗药性的一个关键因素.
- 需要对Hh信号传输的转录机制进行进一步的研究,以克服抵抗.
- 准Hh通路为克服癌症抗药性提供了一个有希望的治疗策略.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
相关概念视频
Treatment Resistant Cancers
Hedgehog Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
